Stand Down IV: Remember This? Alta Vista Cancels IPO. David Wetherell Takes a $2...
We are going through some of our very old 'incubator files' back from when we ran the Incubator Stock Review, a spinoff from the...
True Nature (TNTY) Mitesco Set to Launch Mitesco PLC Incubator — Aligns With Matheson...
Hires Legal Powerhouse Matheson as Counsel and Advisor on its European Acquisitions Efforts.
Established in 1825 in Dublin, Ireland Matheson has offices in Cork, London,...
Adding Citius (CTXR) $0.55 to Watch List.
Best Presentation at Dawson James Conference.
We attended the Dawson James Conference on October 29th, which had over 20 medtech and biotech companies. The two...
What We’re Watching.
“Biotech, Beverages and Bears - Oh My!”
— Daniel K. McMahon
Headlines this week from winners in the past and just maybe, from some major winners...
True Nature (TNTY) Readies Launch of Mitesco: “The Medtech Incubator”
ATLANTA, GA, Nov. 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- True Nature Holding, Inc. (OTCQB: TNTY, “the Company”) today announced that is has...
Initiating Coverage on Mitesco (MITI) FKA True Nature Holdings (TNTY) $0.02. Adding to Watch...
Click here to download.
Medtech Incubator in Final Stages of Launch.
TrueNature (TNTY) Has Spent the Past Year Gearing Up. News of a Launch and First Incubation Effort Could be Around the Corner and Attract...
Emerald Organic (EMOR) to License Therapeutics Portfolio from Amarantus Bioscience Holdings (AMBS).
The portfolio includes treatments for Alzheimer’s disease, ADHD, Parkinson’s disease, vision loss and severe burns. Amarantus to receive Emerald Organics Preferred Stock for the...
Dyadic (DYAI) $7.00 Called a ‘Gamechanger’ – Gets $14 Price Target.
Highly Respected Wall Street Analyst Jason Kolbert Issues $14.00 Price Target On Dyadic.
Analyst Take: "Potential to be Revolutionary. Dyadic’s C1 shows potential in...
Healthcare Incubators and Wearable Devices.
Originally published August 22, 2019
The Global Wearable Devices Market is expected to exceed more than $51.50 billion by 2022 at a CAGR of 15...















